Mayaro virus: the state-of-the-art for antiviral drug development

HIGHLIGHTS

• who: Ana Paula Andreolla and collaborators from the Molecular, Instituto Carlos Chagas, Curitiba, PR, Brazil Departamento Biologia Celular Molecular, Universidade Federal do Paraná, Curitiba, PR, Brazil have published the paper: Mayaro Virus: The State-of-the-Art for Antiviral Drug Development, in the Journal: Viruses 2022, 14, 1787. of /2022/
• what: In this review, the authors describe the state-of-the-art on promising substances/molecules with anti-MAYV activity, which are demonstrated in Figure 3.
• future: Studies are needed to define the precise budding mechanism of alphaviruses from infected cells.

 

If you want to have access to all the content you need to log in!

Thanks :)

Username or Email

Password

Remember me

Lost your password?

If you don't have an account, you can create one here.